{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:51:26Z","timestamp":1767858686254,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ajog.2016.06.036","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T13:02:39Z","timestamp":1467118959000},"page":"750.e1-750.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0554-132X","authenticated-orcid":false,"given":"Mostafa A.","family":"Borahay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques G.","family":"Baillargeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokhan S.","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren F.","family":"Boehning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Fang","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2016.06.036_bib1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.06.036_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.036_bib3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.fertnstert.2014.07.008","article-title":"Alternative therapies in management of leiomyomas","volume":"102","author":"Patel","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2016.06.036_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/GRF.0000000000000171","article-title":"An evidence-based approach to the medical management of fibroids: a systematic review","volume":"59","author":"Bartels","year":"2016","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.036_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijgo.2015.04.051","article-title":"Prevalence, morbidity, and current medical management of uterine leiomyomas","volume":"131","author":"Drayer","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2016.06.036_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/AOG.0b013e318183fbab","article-title":"Alternatives to hysterectomy in the management of leiomyomas. ACOG practice bulletin","volume":"112","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.036_bib7","doi-asserted-by":"crossref","first-page":"943635","DOI":"10.1155\/2012\/943635","article-title":"Innovative oral treatments of uterine leiomyoma","volume":"2012","author":"Sabry","year":"2012","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.ajog.2016.06.036_bib8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/01.AOG.0000285997.38553.4b","article-title":"Hysterectomy rates in the United States, 2003","volume":"110","author":"Wu","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.036_bib9","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.036_bib10","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Nielsen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.06.036_bib11","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrc1751","article-title":"Statins and cancer prevention","volume":"5","author":"Demierre","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajog.2016.06.036_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2003-37501","article-title":"Statins can inhibit proliferation of human breast cancer cells in\u00a0vitro","volume":"111","author":"Seeger","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ajog.2016.06.036_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.5414\/CPP42695","article-title":"Inhibitory effect of statins on the proliferation of human breast cancer cells","volume":"42","author":"Muck","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ajog.2016.06.036_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2407-10-103","article-title":"Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance","volume":"10","author":"Martirosyan","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajog.2016.06.036_bib15","first-page":"1180","article-title":"Lipophilic but not hydrophilic statins selectively induce cell death in gynecological cancers expressing high levels of HMGCoA reductase","volume":"14","author":"Kato","year":"2010","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.ajog.2016.06.036_bib16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0301-472X(03)00192-9","article-title":"Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9","volume":"31","author":"Chapman-Shimshoni","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.ajog.2016.06.036_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1158\/1055-9965.EPI-07-0531","article-title":"Statin induces apoptosis and cell growth arrest in prostate cancer cells","volume":"17","author":"Hoque","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajog.2016.06.036_bib18","doi-asserted-by":"crossref","first-page":"925A","DOI":"10.1378\/chest.1381729","article-title":"Statin use is associated with decreased local recurrence and improved overall survival in resectable non-small cell lung cancer (NSCLC)","volume":"142","author":"Ramakrishna","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ajog.2016.06.036_bib19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ijc.23593","article-title":"Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice","volume":"123","author":"Cho","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2016.06.036_bib20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ygyno.2014.04.007","article-title":"Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials","volume":"133","author":"Liu","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2016.06.036_bib21","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2004.02.027","article-title":"The risk of cancer in users of statins","volume":"22","author":"Graaf","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2016.06.036_bib22","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2008-2802","article-title":"Simvastatin protects against the development of endometriosis in a nude mouse model","volume":"94","author":"Bruner-Tran","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2016.06.036_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.111.098806","article-title":"Simvastatin decreases invasiveness of human endometrial stromal cells","volume":"87","author":"Sokalska","year":"2012","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2016.06.036_bib24","doi-asserted-by":"crossref","first-page":"E463","DOI":"10.1210\/jc.2012-3402","article-title":"Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis","volume":"98","author":"Sokalska","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2016.06.036_bib25","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/humrep\/del505","article-title":"High-dose atorvastatin causes regression of endometriotic implants: a rat model","volume":"22","author":"Oktem","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2016.06.036_bib26","doi-asserted-by":"crossref","first-page":"35075","DOI":"10.1074\/jbc.M114.583575","article-title":"Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells","volume":"289","author":"Borahay","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ajog.2016.06.036_bib27","doi-asserted-by":"crossref","first-page":"196.e1","DOI":"10.1016\/j.ajog.2015.03.055","article-title":"Novel effects of simvastatin on uterine fibroid tumors: in\u00a0vitro and patient-derived xenograft mouse model study","volume":"213","author":"Borahay","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.036_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.ASW.0000392922.30229.b3","article-title":"A\u00a0matched cohort study of the risk of cancer in users of becaplermin","volume":"24","author":"Ziyadeh","year":"2011","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.ajog.2016.06.036_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.contraception.2008.06.012","article-title":"Risk of hyperkalemia in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"78","author":"Loughlin","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2016.06.036_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1074248409360357","article-title":"Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study","volume":"15","author":"Loughlin","year":"2010","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.ajog.2016.06.036_bib31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinylestradiol\/drospirenone","volume":"110","author":"Seeger","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.036_bib32","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1345\/aph.1Q239","article-title":"Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates","volume":"45","author":"Baillargeon","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajog.2016.06.036_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.ajog.2016.06.036_bib34","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"12","author":"Vandenbroucke","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.ajog.2016.06.036_bib35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-0609.2007.00902.x","article-title":"First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma","volume":"79","author":"Schmidmaier","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ajog.2016.06.036_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0163-7258(99)00045-5","article-title":"New insights into the pharmacodynamic and pharmacokinetic properties of statins","volume":"84","author":"Corsini","year":"1999","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajog.2016.06.036_bib37","first-page":"483","article-title":"Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer","volume":"2","author":"Thibault","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajog.2016.06.036_bib38","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","article-title":"Uterine fibroids: the elephant in the room","volume":"308","author":"Walker","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajog.2016.06.036_bib39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.nano.2008.11.004","article-title":"Formation of simvastatin nanoparticles from microemulsion","volume":"5","author":"Margulis-Goshen","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ajog.2016.06.036_bib40","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1039\/c1mb05143a","article-title":"Nucleolipid nanovectors as molecular carriers for potential applications in drug delivery","volume":"7","author":"Simeone","year":"2011","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.ajog.2016.06.036_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4155\/tde.12.144","article-title":"Nanomedicine for uterine leiomyoma therapy","volume":"4","author":"Ali","year":"2013","journal-title":"Ther Deliv"},{"key":"10.1016\/j.ajog.2016.06.036_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.111.004994","article-title":"Pharmacological actions of statins: a critical appraisal in the management of cancer","volume":"64","author":"Gazzerro","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ajog.2016.06.036_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0165-6147(97)01147-4","article-title":"Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors","volume":"19","author":"Hamelin","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ajog.2016.06.036_bib44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/0049825031000066259","article-title":"Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatin","volume":"33","author":"Nezasa","year":"2003","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ajog.2016.06.036_bib45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1358\/mf.2003.25.6.769652","article-title":"Clinical pharmacokinetics of statins","volume":"25","author":"Garcia","year":"2003","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.ajog.2016.06.036_bib46","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1475-6773.2005.00444.x","article-title":"Measuring diagnoses: ICD code accuracy","volume":"40","author":"O'Malley","year":"2005","journal-title":"Health Serv Res"},{"key":"10.1016\/j.ajog.2016.06.036_bib47","doi-asserted-by":"crossref","DOI":"10.1097\/00005650-200208001-00004","article-title":"Assessing comorbidity using claims data: an overview","volume":"40","author":"Klabunde","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.ajog.2016.06.036_bib48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2013.08.008","article-title":"The health disparities of uterine fibroid tumors for African American women: a public health issue","volume":"210","author":"Eltoukhi","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.036_bib49","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ahj.2013.02.011","article-title":"Gender and racial disparities in adherence to statin therapy: a meta-analysis","volume":"165","author":"Lewey","year":"2013","journal-title":"Am Heart J"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816303817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816303817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:10:03Z","timestamp":1757589003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937816303817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0002937816303817"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2016.06.036","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2016.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}